The India-UK FTA is poised to significantly boost India's pharmaceutical and medical device sectors. Tariff relief and streamlined regulations are expected to drive exports, granting easier access to the UK market. Indian companies, particularly in generics and biosimilars, can anticipate expanded market presence and faster product approvals.